MedTrace Logo

Predictors of Sepsis in Ex-Preterm Infants

NCT03433846 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 40

Last updated 2022-05-20

No results posted yet for this study

Summary

The aims of this study are to:

* Assess whether ex-preterm infants have a persistently immature immune system, which may decrease their ability to respond to infections, when they reach term-corrected gestational age.
* Examine whether clinical history, nutrition status, and microbiome composition are linked to the immune composition of term and ex-preterm infants and whether these variables can be used to predict the risk of developing sepsis or having an immunologic disease.

Conditions

Sponsors & Collaborators

Principal Investigators

  • Amy O'Connell, MD · Boston Children's Hospital

Eligibility

Min Age
0 Days
Max Age
2 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-04-18
Primary Completion
2022-01-01
Completion
2022-05-01

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03433846 on ClinicalTrials.gov